| 000 | 01312nam a2200313 a 4500 | ||
|---|---|---|---|
| 001 | vtls000068300 | ||
| 003 | KUKTEM | ||
| 005 | 20251125093905.0 | ||
| 008 | 130129t2010 enka f 001 0 eng d | ||
| 020 | _a9781849730457 (set) | ||
| 020 | _a9781849730631 (v. 1) | ||
| 020 | _a9781849730648 (v. 2) | ||
| 039 | 9 |
_a201311130944 _bsaini _c201301290917 _dasmadi _y201301290913 _zasmadi |
|
| 040 | _aUMP | ||
| 090 | _aRC523 .E44 2010 | ||
| 245 | 0 | 0 |
_aEmerging drugs and targets for Alzheimer’s disease / _cedited by Ana Martinez |
| 260 |
_aCambridge : _bRoyal Society of Chemistry, _cc2010 |
||
| 300 |
_a2 v. : _bill. ; _c24 cm. |
||
| 490 | 0 |
_aRSC drug discovery series, _x2041-3203 ; _vno. 2-3 |
|
| 504 | _aIncludes bibliographical references and index | ||
| 505 | 0 | _av. 1. Beta-amyloid, tau protein and glucose metabolism -- v. 2. Neuronal plasticity, neuronal protection and other miscellaneous strategies | |
| 650 | 0 |
_aAlzheimer’s disease _xChemotherapy |
|
| 650 | 0 | _aDrug targeting | |
| 700 | 1 |
_aMartiÌnez, Ana, _d1961- |
|
| 710 | 2 | _aRoyal Society of Chemistry (Great Britain) | |
| 830 | 0 |
_aRSC drug discovery series ; _v2 |
|
| 830 | 0 |
_aRSC drug discovery series ; _v3 |
|
| 999 |
_aVIRTUA40 _c69239 _d69245 |
||
| 999 | _aVTLSSORT0080*0200*0201*0202*0400*0900*2450*2600*3000*4900*5040*5050*6500*6501*7000*7100*8300*8301*9992 | ||